pharmatechoutlook

Big Data in Healthcare

Bob Oliver, President and CEO, Otsuka America Pharmaceutical, Inc.

Big Data in Healthcare

The impact of big data is being felt in every industry, but the impact on pharma is amplified by the convergence of science and technology.

Read more

Improving Clinical Studies and Benefitting Patients

Margaretta Nyilas, MD, Senior Vice President, Clinical Management & Business Operations, Otsuka Pharmaceutical Development & Commercialization. Inc.

Improving Clinical Studies and Benefitting Patients

The steady pace of new disruptive technologies continues to transform our personal lives, as businesses also continue to realize increasing efficiencies and cost reductions.

Read more

From Transactional to Translational: Bridging the Bench to Bedside Gap

Michael Murphy, Chief Medical and Scientific Officer, Worldwide Clinical Trials

From Transactional to Translational: Bridging the Bench to Bedside Gap

In its genesis CRO and sponsor relationships were built around single points of contact, an overflow and capacity based business model with a “feast versus famine” business cycle and a transactional exchange of services....

Read more

The Coming Era of High Performance Medicine

Jason Burke, System VP, Enterprise Analytics & Data Sciences, UNC Health Care

The Coming Era of High Performance Medicine

Why can we predict hurricanes and snow storms days to weeks in advance, but healthcare struggles to know what will be happening with patients tomorrow?

Read more

Taking Clinical Data Management into the Future with Big Data Integrations in the Cloud

Temitope Keyes, VP of Business Development, ThoughtSphere

Taking Clinical Data Management into the Future with Big Data Integrations in the Cloud

It is hard to think of an industry that has not, or could not, benefit from the scalability and ease of cloud technology.

Read more

The Challenge of Complex Biologics Development

Ron Guido, VP Regulatory Affairs, IRX Therapeutics

The Challenge of Complex Biologics Development

The emergence of biosimilars has highlighted the challenges involved in manufacturing large, complex biological products.

Read more

Data Management beyond Clinical Trials

Steve Cutler, COO, ICON plc [NASDAQ:ICLR]

Data Management beyond Clinical Trials

Electronic Health Records (EHRs) exist to aid in the delivery of care and the administration of health systems.

Read more

Can Expanding Data Sources in Pharma lead to Faster Drug Development?

James Streeter, Global VP Life Sciences Strategy, Oracle Health Sciences

Can Expanding Data Sources in Pharma lead to Faster Drug Development?

It's a logical conclusion that expanding data sources in clinical trials can lead to more therapies, but does this additional data speed up or slow down a clinical trial?

Read more

How Pharma CIOs Can Use Big Data Techniques to Improve Drug Safety

Christy Wilson, Senior Director, Pharma and Biotech Segment, Elsevier’s R&D Solutions

How Pharma CIOs Can Use Big Data Techniques to Improve Drug Safety

For pharmaceutical companies, the safety of their products is of paramount concern.

Read more

Enterprise Solution Design Principles

Leo Barella, VP, Enterprise Architecture, AstraZeneca [NYSE:AZN]

Enterprise Solution Design Principles

Architectural or engineering principles are the cornerstone of the Enterprise Architecture.

Read more

New Editions